|
|
||||||||
Department of Physiology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
| |
ABSTRACT |
|---|
|
|
|---|
On the basis
of the high level of P2X receptor expression found in phrenic
motoneurons (MN) in rats (Kanjhan et al., J Comp Neurol
407: 11-32, 1999) and potentiation of hypoglossal MN inspiratory activity by ATP (Funk et al., J Neurosci 17:
6325-6337, 1997), we tested the hypothesis that ATP receptor
activation also modulates phrenic MN activity. This question was
examined in rhythmically active brain stem-spinal cord preparations
from neonatal rats by monitoring effects of ATP on the activity of
spinal C4 nerve roots and phrenic MNs. ATP produced a rapid-onset,
dose-dependent, suramin- and
pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid
4-sodium-sensitive increase in C4 root tonic discharge and a 22 ± 7% potentiation of inspiratory burst amplitude. This was followed by a
slower, 10 ± 5% reduction in burst amplitude. ATP
S, the
hydrolysis-resistant analog, evoked only the excitatory response. ATP
induced inward currents (57 ± 39 pA) and increased repetitive firing of phrenic MNs. These data, combined with persistence of ATP
currents in TTX and immunolabeling for P2X2 receptors in
Fluoro-Gold-labeled C4 MNs, implicate postsynaptic P2 receptors in the
excitation. Inspiratory synaptic currents, however, were inhibited by
ATP. This inhibition differed from that seen in root recordings; it did
not follow an excitation, had a faster onset, and was induced by
ATP
S. Thus ATP inhibited activity through at least two
mechanisms: 1) a rapid P2 receptor-mediated inhibition and
2) a delayed P1 receptor-mediated inhibition associated with
hydrolysis of ATP to adenosine. The complex effects of ATP on phrenic
MNs highlight the importance of ATP as a modulator of central motor outflows.
P2 receptors; adenosine; immunohistochemistry; rat; neonate
| |
INTRODUCTION |
|---|
|
|
|---|
ADENOSINE-5'-TRIPHOSPHATE (ATP) acts on neurons through activation of two classes of purinergic receptors designated P2X and P2Y. P2X receptors, comprising seven subtypes (P2X1-7) and several splice variants, are ionotropic, ligand-gated ion channels that mediate cation-selective inward currents involved in fast neurotransmission (25). P2Y receptors, comprising at least 11 subtypes (P2Y1-11), are G protein-coupled receptors that signal through slower second messenger systems (25). After initial observations that ATP contributes to fast synaptic transmission at some central synapses (12, 13), interest in the role of extracellular ATP in signaling within the central nervous system (CNS) has grown almost exponentially. ATP receptors are widely distributed throughout the CNS (7, 23, 50, 61, 63), and due to receptor diversity, their activation produces a variety of effects. Purinergic signaling is further complicated by the fact that ATP signaling is normally associated with rapid hydrolysis of ATP to adenosine (11, 21), which, through activation of pre- (3, 10, 31) and postsynaptic (49) P1 receptors (A1 adenosine receptors) has widespread inhibitory actions.
Our understanding of the properties of purinergic receptors in expression systems is growing considerably. However, unravelling the physiological significance of ATP signaling in the CNS lags behind. A role for ATP in synaptic transmission and modulation of synaptic activity is best established in sensory systems (9, 59). The ubiquitous expression of P2 receptors in motoneurons (MNs) (7, 23) suggests an important role for ATP in controlling motor activity, but physiological evidence is limited. In Xenopus, an interaction between the excitatory actions of ATP and the inhibitory actions of adenosine has been implicated in control of episodic motor patterns (8). In mammalian CNS, ATP receptors are distributed throughout respiratory regions of the ventrolateral medulla (63), and their activation modulates the activity of some respiratory neurons. In addition, by virtue of the pH sensitivity of the P2X2 subunit, ATP receptors may contribute to the central chemosensitivity of the respiratory motor network (55, 58). At the level of motor outflow, evidence is limited to the ATP-mediated excitation of hypoglossal (XII) MNs and potentiation of XII nerve inspiratory activity (15).
To further investigate the role of ATP acting at P2 receptors in controlling motor outputs, this study examined its effects on the activity of phrenic MNs and their inspiratory-related output in rhythmically active brain stem-spinal cord preparations from neonatal rats. We focussed on phrenic MNs, which innervate the main inspiratory pump muscle, the diaphragm, because purines acting at presynaptic P1 receptors profoundly inhibit glutamatergic inspiratory inputs to these MNs (10), but the effects of purines at P2 receptors are not known. In addition, this analysis allowed comparison of the effects of ATP on phrenic MNs with those previously described by our laboratory on XII MNs (15). Cervical spinal MNs and XII MNs express different P2X transcripts (7). Thus differential modulation of MNs controlling pump and airway muscles by ATP could lead to a mismatch in inspiratory output of these two pools and contribute to the pathology of sleep-related disorders of breathing (19). This work has previously been presented in abstract form (44).
| |
METHODS |
|---|
|
|
|---|
Electrophysiology
Brain stem-spinal cord preparation. Experiments were performed on brain stem-spinal cord preparations from neonatal Wistar rats ranging in age from postnatal day 0 to day 3 (P0 to P3, n = 39). Preparations were produced by using methods described previously (43, 52). Briefly, animals were anesthetized with ether and decerebrated. The brain stem-spinal cord was isolated in artificial cerebrospinal fluid (aCSF) containing (in mM) 120 NaCl, 3 KCl, 1.0 CaCl2, 2.0 MgSO4, 26 NaHCO3, 1.25 NaH2PO4, and 20 D-glucose, pH 7.4, equilibrated with 95% O2-5% CO2, at 20-22°C. Preparations extended from the caudal-pontine level rostrally to approximately the 7th cervical segment caudally. Once dissected free, the preparation was pinned down with the ventral surface up on Sylgard resin in a recording chamber perfused with aCSF. The volume of the recording chamber was 10 ml for C4 nerve root recording experiments (flow rate of ~15 ml/min) and 2 ml for whole cell recording experiments (2 ml/min). After the removal of dura mater, pia mater was scraped from the ventral surface of the spinal cord just lateral to midline at the level of the C4 roots to facilitate drug diffusion and to allow access for patch pipettes. Bath temperature was gradually increased to 26-27°C before recording.
Nerve root recordings.
Inspiratory MN activity was recorded from severed ends of C4 roots by
using suction electrodes (80- to 100-µm internal diameter). Signals
were amplified, band-pass filtered (100 Hz to 3 kHz), full-wave
rectified, integrated by using a leaky integrator (
= 25 ms),
and displayed on a chart recorder and an oscilloscope. Signals were
also recorded on videotape via pulse code modulation (Vetter model 402 or 3000A) for storage and off-line analysis.
Whole cell recording.
Intracellular recordings from phrenic MNs (n = 22) were
made with the blind whole cell patch-clamp recording technique
(4). Patch pipettes (4.0-5.5 M
; 1.5- to 2-µm tip
size) were pulled on a horizontal puller (Sutter P-97) from filamented
borosilicate glass (Clark/WPI; 1.2-mm outside diameter) and filled with
solution containing (in mM) 125 potassium-gluconate, 5 NaCl, 1 CaCl2, 10 HEPES, 10 BAPTA, and 2 ATP (Mg2+
salt). Intracellular solution pH was adjusted to 7.3 with 5 M KOH.
Signals were amplified and filtered with a patch-clamp amplifier (low-pass 5-kHz Bessel filter, Axopatch 1D, Axon Instruments).
10
mV, 3.0 ms). Series resistance (mean of 15 ± 5 M
) was monitored throughout the experiments. Data were discarded if they changed by >5% between control and test conditions. Voltage-current (V-I) relationships were obtained in current clamp by
applying a series of current steps (500 ms, +50 to
300 pA). In
voltage clamp, current-voltage (I-V) relationships were
obtained by applying a series of 5-mV voltage steps (+15 to
35 mV
from resting membrane potential). Cell input resistance
(RN) was calculated from the slope or the
inverse of the slope of a least-squares regression line fitted to
V-I or I-V curves, respectively.
Neurons included in the database satisfied the criteria previously
described for phrenic MNs (10, 34). Briefly, they had resting membrane potentials of at least
60 mV, received rhythmic synaptic drive currents/potentials in phase with inspiratory burst activity recorded from C1 or C4 ventral roots, produced action potentials that overshot 0 mV, and were in the C4 segment 110-260 µm below the ventral surface.
Drug application.
Effects of P2X receptor agonists and antagonists on C4 root output were
investigated by locally applying drugs over the phrenic MN column by
pressure injection (controlled by solenoid valves) from
triple-barrelled pipettes. Drugs used included ATP disodium salt
(ATP-Na+, Sigma Chemical), ATP Mg2+
salt (ATP-Mg2+, Sigma Chemical),
adenosine-5'-0-(3-thiotriphosphate) (ATP
S, hydrolysis
resistant P2 receptor agonist; Boehringer Mannheim),
,
-methylene
ATP [P2X1,3 receptor agonist (7); Sigma
Chemical], GABA (Sigma Chemical),
pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid [PPADS,
P2X1-3,5 receptor antagonist (7); RBI], and suramin hexasodium [general P2 receptor antagonist; among P2X
receptors, it affects P2X1-3,5 (7);
RBI].
S: 10 mM) were applied for
60 s. For experiments investigating antagonism by the general P2
receptor antagonist suramin (100 µM) or the P2X selective antagonist
PPADS (50 µM), 2-min local applications of antagonists preceded 60-s
applications of 5 mM ATP.
Similar procedures were used for application of drugs during whole cell
recording experiments, with the exception that the injection pipette
was placed as close as possible to the site where the patch electrode
entered the spinal cord (i.e., choice of injection site was not based
on inhibition of C4 output by GABA). Experiments designed to test the
effects of ATP on repetitive firing behavior of phrenic MNs required
prolonged application of ATP (2-5 min).
A minimum of 15 min was allowed between consecutive, 60-s agonist
applications. Preliminary experiments established that this delay
ensured response reproducibility. Shorter recovery periods were often
associated with response attenuation, perhaps reflecting incomplete
recovery from receptor desensitization. For experiments designed to
examine repetitive firing behavior that required longer agonist
application, a single trial was performed.
Data analysis. Effects of applied drugs on peak amplitude of integrated C4 inspiratory bursts were assessed with custom-written LabVIEW acquisition and analysis protocols. Response time course was calculated by averaging inspiratory burst amplitudes in 1-min bins before drug applications, in 30-s bins for the first 2 min after drug onset, in 1-min bins for the next 4 min, and in 2-min bins for the following 8 min. In order not to overestimate the effects of ATP on inspiratory burst amplitude, measurements were corrected for shifts in baseline associated with increased tonic discharge (51).
A separate analysis procedure was used to assess the maximum potentiating and inhibitory effects of ATP on burst amplitude. The short duration of the peak responses made it unlikely that the largest (or smallest) bursts would all fall within the same 30-s time bin. The time of peak response relative to drug onset was also likely to vary between animals due to small differences in pipette position relative to the phrenic MN column. Thus the time binning procedure used to calculate average time course was likely to underestimate the peak magnitude of these responses. Maximum potentiation and maximum inhibition of burst amplitude were therefore calculated relative to control from a moving average of the burst amplitude of five consecutive bursts. Maximum potentiation was taken as the largest value occurring within 2 min of the onset of drug application. Maximum inhibition was taken as the lowest value occurring up to 7 min after the onset of drug application. To investigate the effects of ATP on inspiratory synaptic currents recorded in phrenic MNs, the total charge transfer per individual inspiratory cycle was measured and averaged before, during, and after drug application by integrating the current associated with each consecutive inspiratory cycle (AxoGraph 4.4 software). Response time course for changes in total charge transfer per inspiratory cycle was calculated as described above for calculating time course of changes in inspiratory burst amplitude. Maximum potentiating effects of ATP on inspiratory synaptic inputs were assessed by comparing currents averaged from three consecutive inputs in the control period, to those averaged over the first three bursts occurring immediately after the application of ATP. Initial whole cell recording experiments indicated that the reduction in inspiratory synaptic current occurred more rapidly than the reduction in C4 root output. Thus inspiratory currents occurring after this brief, three-cycle window were excluded due to the potentially confounding effects of adenosine. Maximum inhibition of synaptic currents during the post-ATP period was calculated from a moving average of three consecutive synaptic currents between 1 and 5 min after the onset of drug application. The effects of ATP on repetitive firing of phrenic MNs were investigated by comparing steady-state firing frequencies before, during, and after drug applications. Steady-state firing frequencies were calculated from the last 400 ms of 1-s current steps (at the time when most spike frequency adaptation had occurred). For comparison between experiments, parameters are reported relative to preinjection levels as means ± SE. Analysis of variance was performed on response time courses for C4 root recording experiments using raw data. Differences were identified with mutually orthogonal contrast coefficients to partition the treatment sum of squares. All other statistical analyses were performed on raw data or normalised data after arcsine transformation, and differences in means were tested with Student t-tests. Values of P < 0.05 were assumed significant.Immunohistochemistry
To retrogradely label MNs (1, 37), neonatal rats (P3 and P7, n = 2) received intraperitoneal injections of 0.04 mg/g body wt of Fluoro-Gold. One to two days after injection, rat pups were anesthetized with ether and decerebrated, and the brain stem-spinal cords were isolated in oxygenated aCSF before fixing the tissue in 5% formaldehyde solution (4°C for 16 h). The tissue was cryoprotected in 10 and 30% sucrose PBS solutions (4°C for 12 h each). The C4 segment was then isolated, frozen in an embedding medium, and sectioned at 30 µm with the use of a cryostat. Sections were processed for P2X2 receptor immunoreactivity by sequential incubation in 1.5% goat serum for 40 min at room temperature, P2X2R96ab rabbit antiserum (1:100; Refs. 23, 24) at 4°C for 16 h, and Alexa 568-conjugated goat anti-rabbit secondary antibody (1:800) at 4°C for 5-6 h. Sections were wet mounted by using Citifluor medium (Alltech). Aside from the initial incubation in goat serum, sections underwent three consecutive 5-min washes in 0.1 M PBS between each incubation step. To assess the specificity of labeling, control sections were concurrently processed in the absence of primary antibody. Sections lacking primary antibody were devoid of labeling. Images were obtained by using standard epifluoresence microscopy (Leica filter blocks D for Flouro-Gold and N2 for Alexa 568).| |
RESULTS |
|---|
|
|
|---|
Effects of ATP on C4 Inspiratory-Related Nerve Output Are Biphasic
To test the effects of ATP on inspiratory-related activity recorded from C4 roots, ATP was applied locally over the phrenic MN column. The C4 root response was typically composed of 1) tonic excitation, 2) potentiation of inspiratory burst amplitude, and 3) a post-ATP decrease in burst amplitude. Contralateral root output was never affected.The increase in tonic activity was apparent as the thickening of the
baseline in the raw C4 root recording (Fig.
1A) and the rise in the
baseline of the integrated signal (Fig. 1B). Both raw and
integrated traces demonstrated a rapid rise in tonic activity within
5 s of application of 10 mM ATP. Tonic activity peaked within
30 s of the 60-s application before steadily declining to baseline
level. The decline in tonic root activity in the continued presence of
drug was suggestive of receptor desensitization. Tonic discharge
typically disappeared 80 s after the onset of 10 mM ATP
applications. It was not apparent during applications of 1 mM ATP.
|
The potentiation of inspiratory burst amplitude was superimposed on the increase in tonic root activity and was most apparent in the rectified, integrated recording of C4 root output (Fig. 1B). Applications of both 1 and 10 mM ATP caused significant increases (11 ± 2.9 and 22 ± 7.3%, respectively) in inspiratory burst amplitude (Fig. 1C). The maximum potentiation typically occurred between 30 and 60 s after the onset of drug application. Burst amplitude was potentiated for ~30 s after application of 1 mM ATP compared with 90 s after 10 mM ATP.
Potentiation was followed by a significant post-ATP decrease in burst
amplitude (10 ± 5.0%) that peaked 5 min after the onset of 10 mM
ATP applications (Fig. 1, B and C). To test the
hypothesis that the inhibition was due to the hydrolysis of ATP and
subsequent actions of adenosine, a hydrolysis resistant analog of ATP,
ATP
S, was applied over the phrenic MN column, and its effects
were compared with those of ATP (Fig. 2).
The maximum potentiation by ATP
S (33 ± 4.6%) was similar
to that produced by ATP (27 ± 7.1%). The duration of
potentiation was, however, greater for ATP
S. Burst amplitude
remained significantly greater than control for 2.5 min after the onset
of ATP
S applications, compared with 1.5 min for ATP. The
post-ATP inhibitory effect was not induced by ATP
S. Burst
amplitude gradually fell to, but never below, control levels.
|
To confirm the involvement of P2 receptors in mediating the effects of
ATP on inspiratory-related output, ATP applications were preceded by
2-min local applications of the nonselective P2 antagonist, suramin, or
the P2X receptor antagonist PPADS (Fig. 3). The inhibitory effects of both
antagonists on responses to 5 mM ATP are shown in Fig. 3, A
and C. Pooled data indicate that local application of
suramin (100 µM) over the phrenic MN column significantly reduced the
maximum potentiation of burst amplitude caused by 5 mM ATP from 30 ± 1.7% under control conditions to 11 ± 3.0% (Fig.
3B, n = 3). ATP responses did not return to
control levels after suramin washout. PPADS (50 µM) significantly
reduced responses to 5 mM ATP from a maximum potentiation of 28 ± 5.5% under control conditions to 12 ± 6.0% (Fig. 3D,
n = 4). Again, responses did not return to control
levels after washout of PPADS. This did not reflect a simple rundown or
desensitization of the actions of ATP because consecutive control
applications at 15-min intervals produced consistent responses for up
to 3 h (longest period tested; data not shown).
|
Multiple Effects of ATP on Individual Phrenic MNs
Postsynaptic effects.
Whole cell recordings from individual phrenic MNs were used to further
investigate the mechanisms by which ATP modulates inspiratory output.
At resting membrane potential (
64 ± 4 mV), 10 mM ATP induced
reversible (Fig. 4A),
suramin-sensitive (Fig. 4B) inward currents (57 ± 39 pA, n = 15) or membrane depolarization (3.6 ± 1.1 mV, n = 11, see Fig. 6A) in all cells
tested. Note that to increase speed of antagonism, the concentration of
suramin used in the whole cell experiments (1 mM) was 10-fold higher
than in the extracellular experiments (Fig. 3). At these higher
concentrations and longer applications, suramin reversibly inhibited
inspiratory synaptic inputs, consistent with the inhibitory effects of
suramin on glutamatergic synaptic transmission at high concentration
(40, 57). ATP-induced currents (n = 3) and
depolarization (n = 1) were not blocked by bath
application of 0.5 µM TTX (not illustrated). Action potential block
was confirmed in all phrenic MNs before drug application. The
P2X1,3 agonist
,
-methylene ATP (10 mM) also induced
inward currents (51 ± 34 pA, n = 2; Fig.
4C). The reversal potentials of ATP-induced currents were
highly variable, showing little or no voltage dependence in 10 of 15 phrenic MNs. In these 10 neurons, current magnitude varied little with
changing membrane potential between approximately
95 and
45 mV. In
the remaining 5 of 15 MNs, currents reversed between
78 and
125 mV,
and one reversed at +15 mV. Changes in RN were
inconsistent and typically <10% (Fig. 4Ab). Increases
>10% were observed in only 3 of 15 phrenic MNs. Averaged across all
phrenic MNs, effects of ATP on RN were not
significant.
|
|
|
Modulation of inspiratory synaptic drive to phrenic MNs.
We next tested the hypothesis that ATP-mediated potentiation of
glutamatergic inspiratory synaptic currents contributed to the increase
in inspiratory burst amplitude recorded from the C4 root. In contrast
to the effects of ATP on C4 burst amplitude, where a potentiation
preceded an inhibition, ATP potentiation of inspiratory synaptic
currents was never observed. In fact, a rapid-onset inhibition was
seen. In some cells, this was apparent as a reduction in peak
inspiratory current (Fig. 7A).
In others, although a reduction in peak current was minimal (Fig.
4A), the total charge transfer per inspiratory cycle was
significantly reduced. Plots showing the time course of the ATP effect
on total charge transfer per inspiratory cycle averaged over 30-s time bins revealed a maximum inhibition of 32 ± 11% (Fig.
7C; n = 7) that occurred between 1 and 2 min
after the onset of ATP application (Fig. 7B). To ensure that
the lack of an excitatory effect of ATP on inspiratory synaptic
currents did not simply reflect the 30-s binning procedure, the charge
transfer of the first three cycles that occurred immediately after the
onset of ATP application was analyzed. By focussing on the first cycles
after ATP application, the intent was to assess changes in current
before significant hydrolysis of ATP to adenosine could obscure any
potentiating effect. This additional analysis, however, failed to
reveal any ATP-mediated potentiation of inspiratory drive (Fig.
7C).
|
S on inspiratory synaptic currents. In contrast to responses in C4 root, ATP
S was as
effective as ATP in inhibiting inspiratory synaptic currents (Fig.
7D; n = 2). To test whether this might
reflect direct activation of presynaptic P2Y receptors, as seen in
hippocampal pyramidal neurons where ATP and ATP
S are similarly
effective and more potent than
,
-methylene ATP (36),
the effects of these three compounds on inspiratory synaptic currents
in phrenic MNs were compared. In two cells to which all three drugs
were applied, ATP
S and ATP caused similar reductions in total
charge transfer per inspiratory cycle, whereas
,
-methylene ATP
produced a much smaller current reduction in one and was without
significant effect in the other (Fig. 7D).
| |
DISCUSSION |
|---|
|
|
|---|
ATP receptors are a diverse family of ligand-gated ion channels that are widely distributed throughout the nervous system. Their role in modulating motor outflow is poorly understood and in mammals is currently limited to analysis of vagal (39) and hypoglossal MNs (15). In this study, we describe a biphasic response to ATP similar to that observed in hypoglossal MNs, reflecting the diverse actions of ATP on membrane properties and inspiratory activity. An initial excitatory phase, comprising a tonic component and a potentiation of inspiratory burst amplitude, lasted 1-2 min and likely reflects the depolarizing actions of ATP on phrenic MNs and its potentiation of repetitive firing. A secondary inhibition followed that appears to be mediated by two mechanisms: a P2 receptor-mediated inhibition and a slower, possibly P1 receptor-mediated inhibition resulting from hydrolysis of ATP to adenosine. These results demonstrate not only the potential importance of ATP and its receptors in modulating inspiratory outflow but the importance of the balance between ATP and its catabolites in controlling phrenic MN excitability.
Mechanisms of ATP-Induced Modulation of C4 Root Activity
Tonic excitation. The rapid increase in tonic discharge evoked from the C4 root by ATP clearly demonstrated the excitatory nature of ATP on spinal MNs. Several pieces of evidence suggest that this effect is due to activation of postsynaptic P2 receptors and phrenic MN depolarization. Not only did MNs in the C4 segment of the spinal cord show immunolabeling for the P2X2 receptor, the increase in tonic discharge was sensitive to suramin and PPADS. In addition, the ATP-induced inward current or depolarization was sensitive to suramin and persisted in the presence of TTX. The ionic basis of this depolarization was not examined. Activation by ATP of a nonselective cationic conductance is likely to have contributed, as this action has been observed in a variety of neuron types (41), including hypoglossal MNs (15). Reduction of a voltage-gated K+ current by ATP, as seen in spinal MNs and pre-MNs of Xenopus (8), may also have contributed to the depolarization. We found both positive and negative reversal potentials for ATP-induced currents and inconsistent changes in RN. One interpretation of the variability is that both ionic mechanisms are operating, but to varying degrees, in individual phrenic MNs, i.e., there may be differential expression of P2 receptor subtypes in phrenic MNs. However, it is also possible that the varied responses and the observation in some phrenic MNs that ATP-current amplitude did not change linearly with voltage reflect a site of current generation that is remote from the recording site and under poor voltage control.
Amplitude potentiation. We initially hypothesized that at least three mechanisms would contribute to the ATP-mediated potentiation of C4 inspiratory burst amplitude including 1) direct phrenic MN depolarization, 2) increased excitability of these MNs, and 3) potentiation of inspiratory synaptic currents.
Just as direct ATP-mediated MN depolarization will have contributed to the tonic component of the response, it is also a likely mechanism contributing to the increase in inspiratory burst amplitude. ATP depolarized all phrenic MNs tested, which would bring them closer to firing threshold and result in a larger output for the same inspiratory input. The observation that ATP-mediated elevation of phrenic MN firing remained when membrane depolarization was offset via injection of direct current suggests that the potentiation of inspiratory output by ATP is also due to increased MN excitability (Fig. 6). This increased excitability may result from closure of channels (e.g., K+ channels) and increased RN in response to ATP. However, RN, as measured via injection of current or voltage steps at the soma, did not change significantly in MNs that showed increased excitability. It is possible, therefore, that ATP-mediated changes in RN occurred in dendritic processes and were not detected at the soma. It is also possible that ATP increased excitability through modulation of currents important in determining phrenic MN repetitive firing properties. Candidates include outward rectifier, A-type and Ca2+-activated K+ currents that regulate the repetitive firing behavior of perinatal phrenic MNs (35). Evidence for ATP-mediated modulation of K+ conductances involved in repetitive firing responses is limited to sympathetic neurons where firing rates increase in response to UTP (14), likely through activation of P2Y1,2,6 receptors and inhibition of M-type K+ and N-type Ca2+ currents (5). The possibility that potentiation of glutamatergic inspiratory inputs to phrenic MNs contributed to the ATP-mediated increase in C4 inspiratory burst amplitude was also explored. ATP modulates glutamatergic transmission to neurons in the substantia gelatinosa (31), the CA3 region of the hippocampus (38), and potentiates glutamatergic inspiratory inputs to XII MNs. ATP, however, did not potentiate inspiratory-related synaptic currents in any phrenic MN tested. Thus ATP-mediated potentiation of inspiratory output does not involve enhancement of glutamatergic transmission. It most likely results from the combined actions of membrane depolarization and increased MN excitability.Receptor subtypes underlying excitatory actions of ATP. Blockade of the ATP-mediated excitation by the general P2Y/P2X receptor antagonist suramin and the P2X receptor antagonist PPADS established that the excitation is mediated via P2 receptors. Furthermore, the similarity in the magnitude of the block by suramin and PPADS supports a primary role for P2X receptors in ATP-mediated potentiation of inspiratory output. The lack of selective ligands makes further pharmacological characterization difficult. To date the composition of most native P2X receptors remains unknown. Efforts to identify receptor subtype are further confounded by the vast receptor diversity that is associated with seven subtypes of P2X receptors (P2X1-7) (25), the potential for heteromeric assembly of receptors (27, 29, 30, 60), and alternative splicing (42).
The time course of the PPADS inhibition and the actions of
,
-methylene ATP, however, provide some insight into the subunit composition of P2X receptors involved in ATP-mediated potentiation of
C4 inspiratory output. As discussed by Collo et al. (7) and Buell et al. (6), PPADS has two main actions on
homomeric P2X receptors. Inhibition of P2X1,
P2X2, and P2X5 receptors by PPADS has a slow
onset and slow, often only partial, recovery. In contrast, inhibition
of P2X3 receptors by PPADS has a rapid onset and recovery.
Although the speed of onset is difficult to assess when drugs are
locally applied to tissue slices, the lack of recovery from PPADS in
this study supports the presence of P2X1, P2X2,
and P2X5 receptors. Generation of inward currents by the
P2X1,3 agonist
,
-methylene ATP further supports the
presence of P2X1 receptors. RNA for five P2X receptor
subunits, including P2X1, P2X2, and
P2X5, has been detected in adult spinal cord MNs, with
signals strongest for P2X2 and weaker for P2X1
and P2X5 probes (6, 7). Immunohistochemical
data in adult (23) and neonatal rats (present study)
localizing P2X2 receptor subunit protein to MNs in the C4
segment support the possibility that P2X2 receptors contribute to the potentiation of C4 inspiratory-related output. Thus
ATP-mediated potentiation of phrenic MN activity is likely to be
mediated, at least in part, by activation of P2X1,
P2X2, and/or P2X5 receptors.
Amplitude inhibition. Whereas the excitatory actions of ATP result from membrane depolarization and increased MN excitability, the final magnitude of the ATP-mediated potentiation of burst amplitude results from an interaction between these potentiating effects and inhibitory mechanisms. In this study, inhibitory effects of ATP were evident in 1) recordings from the C4 root as a delayed, secondary inhibition of inspiratory burst amplitude and 2) whole cell recordings from phrenic MNs as a more rapid reduction in inspiratory synaptic currents.
Mechanisms remain to be defined, but data suggest two contributing factors. First, the secondary inhibition of C4 inspiratory burst amplitude evoked in response to ATP, but not to ATP
S, the hydrolysis-resistant analog (20), in conjunction with the
prolonged excitatory actions of ATP
S relative to ATP, suggests
that the post-ATP inhibition results from the actions of adenosine at
P1 receptors. Extracellular ATP is rapidly degraded to
adenosine by membrane-bound ectonucleotidases (11, 21),
which are widespread throughout the brain and spinal cord
(64). Indeed, adenosine, derived from the hydrolysis of
ATP, has widespread inhibitory effects on synaptic transmission
(11, 21, 31). Most relevant to the present study,
ATP-mediated potentiation of XII nerve inspiratory output in
rhythmically active medullary slice preparations is followed by an
inhibition similar in magnitude and time course to that described here
for C4 inspiratory output. Although not tested in phrenic MNs, this
inhibition in XII is blocked by the general P1 receptor antagonist
theophylline (15). Endogenous adenosine also inhibits
inspiratory drive to both phrenic and XII MNs via activation of
presynaptic A1 adenosine receptors (3, 10).
Taken together, data are consistent with the possibility that
hydrolysis of ATP to adenosine and activation of presynaptic A1 receptors contributes to the secondary inhibitory action
of ATP on C4 inspiratory output.
In contrast to the delayed inhibition of C4 burst amplitude, the
ATP-mediated inhibition of inspiratory synaptic currents had a rapid
onset and was also evoked by ATP
S. Thus, in addition to the
putative adenosine-mediated inhibition of inspiratory activity, a more
rapid P2 receptor-mediated inhibitory mechanism may contribute. ATP-mediated activation of local inhibitory interneurons, including Renshaw cells, is unlikely to participate in the inhibition. First, recurrent inhibition of phrenic MNs is minimal relative to other spinal
MN pools (18, 33, 43). Second, ATP-mediated excitation of
Renshaw cells, or any other local inhibitory neuron, would lead to
tonic release of glycine/GABA, which would manifest in an outward
current (43, 47). This was not apparent in any recording.
Inhibition of inspiratory input to phrenic MNs by presynaptic P2X
receptors is also unlikely. Although presynaptic P2X receptors increase
the spontaneous release of neurotransmitter (including glutamate) (for
review, see Ref. 26), evidence for P2X receptor-mediated inhibition of glutamatergic transmission is lacking. A P2Y
receptor-mediated inhibition of glutamatergic excitatory postsynaptic
potentials, as seen in hippocampal pyramidal cells (36),
may contribute. This presynaptic P2Y inhibitory mechanism is activated
by ATP
S and ATP and only partially by
,
-methylene ATP. It
therefore has a similar pharmacology to the response observed here in
two phrenic MNs. Additional experiments are required to verify this putative mechanism.
In summary, we propose that the biphasic time course of the response to
ATP recorded from the C4 root is determined through an interaction of
multiple effects. In the initial phase, membrane depolarization and
increased MN excitability predominate to produce burst amplitude
potentiation, although the inspiratory synaptic input to phrenic MNs
actually diminishes as a result of a presynaptic, possibly P2Y
receptor-mediated, inhibition. The potentiation then decreases as ATP
is hydrolyzed to adenosine, which activates a slower time course
inhibition mediated through presynaptic A1 receptors.
Functional Significance of ATP as a Modulator of Phrenic MN Activity
Modulation of phrenic and XII MN (15) excitability by extracellular ATP highlights the potential importance of this compound and the diversity of P2 receptors to respiratory control. A complete understanding of the functional significance of this signaling system will ultimately require several issues to be addressed. Most urgent is the need for development of specific P2 receptor antagonists, as these are required to test for endogenous actions of ATP, establish the source of ATP inputs, and define the factors affecting release. Direct support for endogenous modulation of inspiratory MN activity is lacking. However, electrophysiological analyses in vivo suggest that ATP receptors on respiratory neurons in the ventrolateral medulla (54, 55, 58), in particular P2X2 receptors whose currents are potentiated by low pH (28), may contribute to central respiratory chemosensitivity. The most likely source of ATP inputs to respiratory networks is from noradrenergic neurons of the brain stem. Not only do these neurons project widely to respiratory neurons and MNs (17, 47), they corelease ATP and norepinephrine (46, 53). The state-dependent activity of noradrenergic locus coeruleus neurons (2) raises the additional possibility that ATP-mediated signaling contributes to diurnal modulation of breathing pattern and MN excitability.The opposing effects of ATP and adenosine and the fact that ATP is hydrolyzed to adenosine at many synapses (11, 21, 31) also suggest that controlling the rate of ATP hydrolysis to adenosine may provide an additional mechanism for modulating ATP-induced excitation. Xenopus embryos, for example, display rhythmic swimming movements that are lengthened by ATP and reduced by adenosine (8). A delicate balance between ATP and adenosine, presumably derived from the breakdown of ATP, has been proposed to form a feedback mechanism that controls duration of swimming episodes and possibly other episodic motor patterns.
Respiratory activity may be another motor pattern under complex purinergic control. Potentiation followed by inhibition of inspiratory output has been recorded in response to exogenous ATP for phrenic and airway MNs (15) in the neonatal rat. Under physiological conditions, alterations in the normal balance between synaptically released ATP and the resultant adenosine may contribute to the biphasic hypoxic ventilatory response. Although elevations in extracellular adenosine during hypoxia are largely believed to reflect release from nonsynaptic sources (45), altered activity of ectoATPases, adenosine transporters, and purinergic neurons must also be considered.
Although progress in establishing the physiological significance of ATP signaling in controlling motor outflow has been slow, interest in the pharmacological actions of ATP receptor activation on motor outflow is high due to the diversity of receptors and the potential for developing drugs to selectively manipulate neuronal and network activity. In this context, understanding the differential modulation of phrenic and airway MNs by P2 and P1 receptors and the mechanisms that control ATP hydrolysis are of interest as a mismatch between activity of phrenic and airway MNs has been implicated in some cases of sudden infant death syndrome as well as obstructive sleep apnea (19, 48). The ATP-mediated excitation of C4 inspiratory output demonstrated in this study was similar in magnitude to that observed previously for XII inspiratory output (15). The concentration of ATP required to produce these effects, however, was an order of magnitude higher for phrenic compared to XII MNs. Thus either phrenic MNs have reduced sensitivity to ATP compared with XII MNs or the inhibitory effects are more potent in phrenic MNs. It is also possible that the reduced sensitivity of phrenic MNs is due in part to reduced drug diffusion to the phrenic vs. XII MN pools. In the neonatal brain stem-spinal cord preparation, the phrenic motor nucleus is located ~200 µm below the ventral surface (32). In the rhythmic slice preparation previously used to study XII MNs, MNs are present near the cut surface of the slice. We minimized diffusion barriers to phrenic MNs in the present study by removing pia mater. The success of this procedure was confirmed by the rapid inhibitory actions of GABA on C4 inspiratory output. Thus different sensitivities of phrenic and XII MNs to ATP may represent real physiological differences.
Whether the effects described here in neonates apply to older animals is not known. P2 receptor expression and physiological actions do change developmentally in some regions (22, 62). Within respiratory networks, however, developmental measurements are limited to the purinergic modulation of XII inspiratory activity where the biphasic effects of ATP at P0 and P10 are virtually indistinguishable (16).
In summary, the complex effects of ATP on respiratory MN output, in conjunction with the ubiquitous expression of ATP receptors on MNs, suggest that ATP receptors and purinergic signaling play an important role in controlling motor outflow from the CNS.
| |
ACKNOWLEDGEMENTS |
|---|
We acknowledge the generous donation of P2X2 receptor antibodies by Dr. Gary Housley.
| |
FOOTNOTES |
|---|
This research was supported by the Health Research Council of New Zealand and the Marsden Fund.
Address for reprint requests and other correspondence: G. D. Funk, Dept. of Physiology, Faculty of Medical and Health Sciences, Univ. of Auckland, Private Bag 92019, 85 Park Road, Grafton, Auckland, New Zealand (E-mail: g.funk{at}auckland.ac.nz).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published December 21, 2001;10.1152/japplphysiol.00475.2001
Received 17 May 2001; accepted in final form 14 December 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Ambalavanar, R,
and
Morris R.
Flouro-gold injected either subcutaneously or intravascularly results in extensive retrograde labeling of CNS neurones having axons terminating outside the blood-brain barrier.
Brain Res
505:
171-175,
1989.
2.
Aston-Jones, G,
and
Bloom FE.
Activity of locus-coeruleus neurons in behaving rats anticipates fluctuations in the sleep-wake cycling.
J Neurosci
1:
876-886,
1981.
3.
Bellingham, MC,
and
Berger AJ.
Adenosine suppresses excitatory glutamatergic inputs to rat hypoglossal motoneurons in vitro.
Neurosci Lett
177:
143-146,
1994.
4.
Blanton, MG,
Lo Turco JJ,
and
Kriegstein AR.
Whole-cell recordings from neurons in slices of reptilian and mammalian cerebral cortex.
J Neurosci Methods
30:
203-210,
1989.
5.
Brown, DA,
Filippov AK,
and
Barnard EA.
Inhibition of potassium and calcium currents in neurones by molecularly-defined P2y receptors.
J Auton Nerv Syst
81:
31-36,
2000.
6.
Buell, G,
Collo G,
and
Rassendren F.
P2X receptors: an emerging channel family.
Eur J Neurosci
8:
2221-2228,
1996.
7.
Collo, G,
North RA,
Kawashima E,
Merlo-Pich E,
Neidhart S,
Surprenant A,
and
Buell G.
Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels.
J Neurosci
16:
2495-2507,
1996.
8.
Dale, N,
and
Gilday D.
Regulation of rhythmic movements by purinergic neurotransmitters in frog embryos.
Nature
383:
259-263,
1996.
9.
Ding, Y,
Cesare P,
Drew L,
Nikitaki D,
and
Wood JN.
ATP, P2X receptors and pain pathways.
J Auton Nerv Syst
81:
289-294,
2000.
10.
Dong, XW,
and
Feldman JL.
Modulation of inspiratory drive to phrenic motoneurons by presynaptic adenosine A1 receptors.
J Neurosci
15:
3458-3467,
1995.
11.
Dunwiddie, TV,
Diao L,
and
Proctor R.
Adenine nucleotides undergo rapid, quantitative conversion to adensine in the extracellular space in rat hippocampus.
J Neurosci
17:
7673-7682,
1997.
12.
Edwards, FA,
Gibb AJ,
and
Colquhoun D.
ATP receptor-mediated synaptic currents in the central nervous system.
Nature
359:
144-147,
1992.
13.
Evans, RJ,
Derkach V,
and
Surprenant A.
ATP mediates fast synaptic transmission in mammalian neurons.
Nature
357:
503-505,
1992.
14.
Filippov, AK,
Webb TE,
Barnard EA,
and
Brown DA.
P2Y2 nucleotide receptors expressed heterologously in sympathetic neurons inhibit both N-type Ca2+ and M-type K+ currents.
J Neurosci
18:
5170-5179,
1998.
15.
Funk, GD,
Kanjhan R,
Walsh C,
Lipski J,
Comer AM,
Parkis MA,
and
Housley GD.
P2 receptor excitation of rodent hypoglossal motoneuron activity in vitro and in vivo: a molecular physiological analysis.
J Neurosci
17:
6325-6337,
1997.
16.
Funk, GD,
Parkis MA,
Selvaratnam SR,
and
Walsh C.
Developmental modulation of glutamatergic inspiratory drive to hypoglossal motoneurons.
Respir Physiol
110:
125-137,
1997.
17.
Hilaire, G,
and
Duron B.
Maturation of the mammalian respiratory system.
Physiol Rev
79:
325-360,
1999.
18.
Hilaire, G,
Khatib M,
and
Monteau R.
Central drive on Renshaw cells coupled with phrenic motoneurons.
Brain Res
376:
133-139,
1986.
19.
Hudgel, DW,
and
Harasick T.
Fluctuation in timing of upper airway and chest wall inspiratory muscle activity in obstructive sleep apnea.
J Appl Physiol
69:
443-450,
1990.
20.
Humphrey, PP,
Buell G,
Kennedy I,
Khakh BS,
Michel AD,
Surprenant A,
and
Trezise DJ.
New insights on P2X purinoceptors.
Naunyn Schmiedebergs Arch Pharmacol
352:
585-596,
1995.
21.
James, S,
and
Richardson PJ.
Production of adenosine from extracellular ATP at the striatal cholinergic synapse.
J Neurochem
60:
219-227,
1993.
22.
Jarlebark, LE,
Housley GD,
and
Thorne PR.
Immunohistochemical localization of adenosine 5'-triphosphate-gated ion channel P2X(2) receptor subunits in adult and developing rat cochlea.
J Comp Neurol
421:
289-301,
2000.
23.
Kanjhan, R,
Housley GD,
Burton LD,
Christie DL,
Kippenberger A,
Thorne PR,
Luo L,
and
Ryan AF.
Distribution of the P2X2 receptor subunit of the ATP-gated ion channels in the rat central nervous system.
J Comp Neurol
407:
11-32,
1999.
24.
Kanjhan, R,
Housley GD,
Thorne PR,
Christie DL,
Palmer DJ,
Luo L,
and
Ryan AF.
Localization of ATP-gated ion channels in cerebellum using P2x2R subunit-specific antisera.
Neuroreport
7:
2665-2669,
1996.
25.
Kennedy, C.
The discovery and development of P2 receptor subtypes.
J Auton Nerv Syst
81:
158-163,
2000.
26.
Khakh, BS,
and
Henderson G.
Modulation of fast synaptic transmission by presynaptic ligand-gated cation channels.
J Auton Nerv Syst
81:
110-121,
2000.
27.
King, BF,
Townsend-Nicholson A,
Wildman SS,
Thomas T,
Spyer KM,
and
Burnstock G.
Coexpression of rat P2X2 and P2X6 subunits in Xenopus oocytes.
J Neurosci
20:
4871-4877,
2000.
28.
King, BF,
Wildman SS,
Ziganshina LE,
Pintor J,
and
Burnstock G.
Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor.
Br J Pharmacol
121:
1445-1453,
1997.
29.
Le, KT,
Babinski K,
and
Seguela P.
Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor.
J Neurosci
18:
7152-7159,
1998.
30.
Lewis, C,
Neidhart S,
Holy C,
North RA,
Buell G,
and
Surprenant A.
Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons.
Nature
377:
432-435,
1995.
31.
Li, J,
and
Perl ER.
ATP modulation of synaptic transmission in the spinal substantia gelatinosa.
J Neurosci
15:
3357-3365,
1995.
32.
Lindsay, AD,
Greer JJ,
and
Feldman JL.
Phrenic motoneuron morphology in the neonatal rat.
J Comp Neurol
308:
169-179,
1991.
33.
Lipski, J,
Fyffe RE,
and
Jodkowski J.
Recurrent inhibition of cat phrenic motoneurons.
J Neurosci
5:
1545-1555,
1985.
34.
Liu, G,
Feldman JL,
and
Smith JC.
Excitatory amino acid-mediated transmission of inspiratory drive to phrenic motoneurons.
J Neurophysiol
64:
423-436,
1990.
35.
Martin-Caraballo, M,
and
Greer JJ.
Development of potassium conductances in perinatal rat phrenic motoneurons.
J Neurophysiol
83:
3497-3508,
2000.
36.
Mendoza-Fernandez, V,
Andrew RD,
and
Barajas-Lopez C.
ATP inhibits glutamate synaptic release by acting at P2Y receptors in pyramidal neurons of hippocampal slices.
J Pharmacol Exp Ther
293:
172-179,
2000.
37.
Merchenthaler, I.
Neurons with access to the general circulation in the central nervous system of the rat: a retrograde tracing study with flouro-gold.
Neuroscience
44:
655-662,
1991.
38.
Motin, L,
and
Bennett MR.
Effect of P2-purinoceptor antagonists on glutamatergic transmission in the rat hippocampus.
Br J Pharmacol
115:
1276-1280,
1995.
39.
Nabekura, J,
Ueno S,
Ogawa T,
and
Akaike N.
Colocalization of ATP and nicotinic ACh receptors in the identified vagal preganglionic neurone of rat.
J Physiol (Lond)
489:
519-527,
1995.
40.
Nakazawa, K,
Inoue K,
Ito K,
Koizumi S,
and
Inoue K.
Inhibition by suramin and reactive blue 2 of GABA and glutamate receptor channels in rat hippocampal neurons.
Naunyn Schmiedebergs Arch Pharmacol
351:
202-208,
1995.
41.
Norenberg, W,
and
Illes P.
Neuronal P2X receptors: localisation and functional properties.
Naunyn Schmiedebergs Arch Pharmacol
362:
324-339,
2000.
42.
North, RA,
and
Barnard EA.
Nucleotide receptors.
Curr Opin Neurobiol
7:
346-357,
1997.
43.
Parkis, MA,
Dong XW,
Feldman JL,
and
Funk GD.
Concurrent inhibition and excitation of phrenic motoneurons during inspiration: phase-specific control of excitability.
J Neurosci
19:
2368-2380,
1999.
44.
Parkis, MA,
Miles GB,
and
Funk GD.
Modulation of rat phrenic motoneuron (PMN) activity in vitro by extracellular ATP.
Soc Neurosci Abstr
25:
118,
1999.
45.
Phillis, JW,
O'Regan MH,
and
Perkins LM.
Adenosine 5'-triphosphate release from the normoxic and hypoxic in vivo rat cerebral cortex.
Neurosci Lett
151:
94-96,
1993.
46.
Poelchen, W,
Sieler D,
Wirkner K,
and
Illes P.
Co-transmitter function of ATP in central catecholaminergic neurons of the rat.
Neuroscience
102:
593-602,
2001.
47.
Rekling, J,
Funk GD,
Bayliss D,
Dong X,
and
Feldman JL.
Synaptic control of motoneuronal excitability.
Physiol Rev
80:
767-852,
2000.
48.
Remmers, JE,
Degroot WJ,
Sauerland EK,
and
Anch AM.
Pathogenesis of upper airway occlusion during sleep.
J Appl Physiol
44:
931-938,
1978.
49.
Schmidt, C,
Bellingham MC,
and
Richter DW.
Adenosinergic modulation of respiratory neurones and hypoxic responses in the anaesthetized cat.
J Physiol (Lond)
483:
769-781,
1995.
50.
Seguela, P,
Haghighi A,
Soghomonian JJ,
and
Cooper E.
A novel neuronal P2x ATP receptor ion channel with widespread distribution in the brain.
J Neurosci
16:
448-455,
1996.
51.
Selvaratnam, SR,
Parkis MA,
and
Funk GD.
Developmental modulation of mouse hypoglossal nerve inspiratory output in vitro by noradrenergic receptor agonists.
Brain Res
805:
104-115,
1998.
52.
Smith, JC,
and
Feldman JL.
In vitro brainstem-spinal cord preparations for study of motor systems for mammalian respiration and locomotion.
J Neurosci Methods
21:
321-333,
1987.
53.
Sperlagh, B,
Sershen H,
Lajtha A,
and
Vizi ES.
Co-release of endogenous ATP and [3H]noradrenaline from rat hypothalamic slices: origin and modulation by
2-adrenoceptors.
Neuroscience
82:
511-520,
1998.
54.
Spyer, KM,
and
Thomas T.
Sensing arterial CO2 levels: a role for medullary P2X receptors.
J Auton Nerv Syst
81:
228-235,
2000.
55.
Spyer, KM,
Thomas T,
and
Ralevic V.
The role of purinoceptors in the chemosensory control of respiration (Abstract).
J Physiol (Lond)
518:
38S,
1999.
56.
Su, CK,
and
Chai CY.
GABAergic inhibition of neonatal rat phrenic motoneurons.
Neurosci Lett
248:
191-194,
1998.
57.
Surprenant, A.
Functional properties of native and cloned P2X receptors.
Ciba Found Symp
198:
208-219,
1996.
58.
Thomas, T,
Ralevic V,
Gadd CA,
and
Spyer KM.
Central CO2 chemoreception: a mechanism involving P2 purinoceptors localized in the ventrolateral medulla of the anaesthetized rat.
J Physiol (Lond)
517:
899-905,
1999.
59.
Thorne, PR,
and
Housley GD.
Purinergic signaling in sensory systems.
Semin Neurol
8:
233-246,
1996.
60.
Torres, GE,
Egan TM,
and
Voigt MM.
Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners.
J Biol Chem
274:
6653-6659,
1999.
61.
Vulchanova, L,
Arvidsson U,
Riedl M,
Wang J,
Buell G,
Surprenant A,
North RA,
and
Elde R.
Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry.
Proc Natl Acad Sci USA
93:
8063-8067,
1996.
62.
Wirkner, K,
Franke H,
Inoue K,
and
Illes P.
Differential age-dependent expression of
2 adrenoceptor and P2 purinoceptor functions in rat locus coeruleus neurons.
Naunyn Schmiedebergs Arch Pharmacol
357:
186-189,
1998.
63.
Yao, ST,
Barden JA,
Finkelstein DI,
Bennett MR,
and
Lawrence AJ.
Comparative study on the distribution patterns of P2x(1)-P2x(6) receptor immunoreactivity in the brain stem of the rat and the common marmoset (Callithrix jacchus): association with catecholamine cell groups.
J Comp Neurol
427:
485-507,
2000.
64.
Zimmermann, H.
Biochemistry, localization, and functional roles of ecto-nucleotidases in the nervous system.
Prog Neurobiol
49:
589-618,
1996.
This article has been cited by other articles:
![]() |
M. F. Ireland, F. C. Lenal, A. R. Lorier, D. E. Loomes, T. Adachi, T. S. Alvares, J. J. Greer, and G. D. Funk Distinct receptors underlie glutamatergic signalling in inspiratory rhythm-generating networks and motor output pathways in neonatal rat J. Physiol., May 1, 2008; 586(9): 2357 - 2370. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Lorier, J. Lipski, G. D. Housley, J. J. Greer, and G. D. Funk ATP sensitivity of preBotzinger complex neurones in neonatal rat in vitro: mechanism underlying a P2 receptor-mediated increase in inspiratory frequency J. Physiol., March 1, 2008; 586(5): 1429 - 1446. [Abstract] [Full Text] |